Secretive Agios Makes Splash with $33M Series A

Image via Wikipedia
Agios Pharmaceuticals, backed by heavy hitters: Third Rock, Flagship and ARCH venture groups, announced it has closed a hefty, $33M Series A financing round.
There is very little substance in the press release or on the Agios website about the company or the technology.
The basic gist though, has to do with modulating the metabolism [...]